Education
About Us
Working with TipRanks
Follow Us
Scandinavian ChemoTech AB Class B (DE:8V6)
FRANKFURT:8V6
Total Valuation
Scandinavian ChemoTech AB Class B has a market cap or net worth of €10.37M. The enterprise value is €161.92M.
Market Cap€10.37M
Enterprise Value€161.92M
Share Statistics
Scandinavian ChemoTech AB Class B has 21,692,312 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,692,312
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Scandinavian ChemoTech AB Class B’s return on equity (ROE) is -2.29 and return on invested capital (ROIC) is -213.98%.
Return on Equity (ROE)-2.29
Return on Assets (ROA)-1.03
Return on Invested Capital (ROIC)-213.98%
Return on Capital Employed (ROCE)-2.14
Revenue Per Employee2.19M
Profits Per Employee-4.27M
Employee Count3
Asset Turnover0.49
Inventory Turnover0.54
Valuation Ratios
The current PE Ratio of Scandinavian ChemoTech AB Class B is ―. Scandinavian ChemoTech AB Class B’s PEG ratio is 0.05.
PE Ratio―
PS Ratio6.36
PB Ratio6.99
Price to Fair Value6.99
Price to FCF-3.17
Price to Operating Cash Flow-8.49
PEG Ratio0.05
Income Statement
In the last 12 months, Scandinavian ChemoTech AB Class B had revenue of 6.57M and earned -13.72M in profits. Earnings per share was -0.59.
Revenue6.57M
Gross Profit4.78M
Operating Income-12.80M
Pretax Income-13.72M
Net Income-13.72M
EBITDA-12.38M
Earnings Per Share (EPS)-0.59
Cash Flow
In the last 12 months, operating cash flow was -9.48M and capital expenditures 0.00, giving a free cash flow of -9.48M billion.
Operating Cash Flow-9.48M
Free Cash Flow-9.48M
Free Cash Flow per Share-0.44
Dividends & Yields
Scandinavian ChemoTech AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.07
52-Week Price Change425.00%
50-Day Moving Average0.36
200-Day Moving Average0.24
Relative Strength Index (RSI)68.90
Average Volume (3m)7.00
Important Dates
Scandinavian ChemoTech AB Class B upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateNov 4, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Scandinavian ChemoTech AB Class B as a current ratio of 1.05, with Debt / Equity ratio of 0.00%
Current Ratio1.05
Quick Ratio0.60
Debt to Market Cap0.00
Net Debt to EBITDA0.08
Interest Coverage Ratio-10.86
Taxes
In the past 12 months, Scandinavian ChemoTech AB Class B has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Scandinavian ChemoTech AB Class B EV to EBITDA ratio is -3.30, with an EV/FCF ratio of -3.10.
EV to Sales6.22
EV to EBITDA-3.30
EV to Free Cash Flow-3.10
EV to Operating Cash Flow-3.11
Balance Sheet
Scandinavian ChemoTech AB Class B has €517.00K in cash and marketable securities with €0.00 in debt, giving a net cash position of €517.00K billion.
Cash & Marketable Securities€517.00K
Total Debt€0.00
Net Cash€517.00K
Net Cash Per Share€0.02
Tangible Book Value Per Share€0.02
Margins
Gross margin is 78.01%, with operating margin of -194.88%, and net profit margin of -208.91%.
Gross Margin78.01%
Operating Margin-194.88%
Pretax Margin-208.91%
Net Profit Margin-208.91%
EBITDA Margin-188.49%
EBIT Margin-190.97%
Analyst Forecast
The average price target for Scandinavian ChemoTech AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―